Avant Immunotherapeutics CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference

NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq:AVAN) today announced that Dr. Una S. Ryan, President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the Needham & Company Sixth Annual Biotechnology & Medical Technology Conference at the New York Palace Hotel in New York City on Wednesday, June 13 at 8:30 am EDT.

MORE ON THIS TOPIC